Royalty Pharma plc Class A Ordinary Shares vs Toyota Motor Corp — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B), while Toyota Motor Corp trades at $185.3 (market cap $217.38B). The key difference: Toyota Motor Corp is far larger — about 8.6× Royalty Pharma plc Class A Ordinary Shares's market cap, and Toyota Motor Corp pays the higher dividend (3.37%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Toyota Motor Corp for 116 Days on average.
| RPRX | TM | |
|---|---|---|
Market Cap | $25.27B | $217.38B |
Volume | 3,671,183 | 291,250 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.96 | $248.29 |
52-Week Low | $35.44 | $166.50 |
Typical Hold Time | 1 Days | 116 Days |
Enterprise Value | $32.50B | $410.96B |
Dividend Yield | 1.66% | 3.37% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Toyota Motor (TM) trades at $186.00, up 1.69% today, with a bearish technical signal but strong fundamentals. The stock shows attractive valuation ratios, including a P/E of 8.38 and P/B of 0.93, and has beaten EPS estimates in recent quarters. Recent news highlights U.S. sales growth and electrification efforts, though production declines in China and floods in Thailand pose challenges. Cash flow turned negative in 2025 but is projected to rebound in 2026.
TM presents a value opportunity with low multiples and consistent profitability, but near-term headwinds from global sales softness and supply chain disruptions warrant caution. Analyst consensus is mixed, with 37.5% buy ratings versus 62.5% hold, reflecting balanced optimism and patience. The stock's outlook hinges on execution in electrification and recovery in key markets like China.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →